Cel Sci Corporation (CVM)

[imanjen13]

After the final protocol is submitted to the FDA before June 21, enrollment of the 212 patients ( 106 for the control and 106 for the multikline users), will hopefully be concluded before the fall. Preliminary positive results should be confirmed within a few weeks thereafter according to the company.

Hopefully these events will be publicized. Stock is seriously undervalued and is deserving of a market cap that is tenfold of current prices. Long and strong here as a believer in the technology.

The kicker would be an approval of the MAA in the UK which will make this treatment the Standard of Care on the other side of the pond.